Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Ratings reports. One ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...

In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week ...

Bionano Genomics (BNGO) announced a study published in the American Journal of Hematology demonstrating the potential utility of optical genome mapping, OGM, for detecting structural variants ...

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

Bionano Genomics, Inc. has announced a webinar to be held on April 15, 2025, featuring Dr. Guilin Tang, the lead author of a recent study published in the American Journal of Hematology.

Cardone Training Technologies, Inc. (CTTI) announces new partnership ... and marketing strategies grounded in Grant Cardone's famed 10X philosophy. This initiative promises to bolster the business ...

After hours: March 17 at 5:55:30 p.m. EDT Loading Chart for TXG ...